Avatar for Infinita Events
Presented by
Infinita Events
Bridging the Gap from Biotech to Clinic.
We help biotechs navigate emerging clinical access pathways.
97 Went

The Network State, Radical Life Extension and Crypto Cities | São Paulo Meetup

Registration
Past Event
Welcome! To join the event, please register below.
About Event

​The Network State by Balaji Srinivasan is a powerful concept that aims to bring on-chain innovation on-land.

​​It seems utopian, but it's already happening. And it's not in the Metaverse, it's in the real world.

​​Several startups cities have sprung up that have real-world jurisdiction and land, e.g. Próspera, Culdesac, Cabin, Itana, Ciudad Morazán.

​Vitalik Buterin's "Zuzalu" has created a new model to catalyze highly aligned online communities into shaping meatspace.

​​The pop-up city model has inspired 100s of new experiments, including Ipe City in Florianópolis Brazil.

​​The time has come for a real movement to emerge.

​​This event will feature key thought leaders that explain this inspiring, but at times confusing new era.

  • ​​Niklas Anzinger is the CEO of Infinita City, building a biotech acceleration district in the jurisdiction of Próspera (Roatán, Honduras)

  • ​​Hugo Mathecowitsch is the founder of Tools for the Commons.

​​​Agenda

​​​The topics of the conversation are the emergence of startup cities & network states, crypto, and decentralized governance as pillars for a self-sovereign governance system, and advancing medical technologies & the science for extending healthy human lifespan.

​​5:30-5:45pm Welcome

​​5:45-6:05pm Niklas Anzinger on Infinita City - Network State x Radical Life Extension

​6:05-6:25pm Hugo Mathecowitsch on Tools for the Commons

​6:25-6:50 Niklas Anzinger - the case for special economic zones

​6:50-7:30 Open Discussion + Q&A

​7:30+ Open End Networking with Snacks & Drinks

Location
Rua Simpatia, 23, Vila Madalena, São Paulo SP, 05436-020, Brasil
Avatar for Infinita Events
Presented by
Infinita Events
Bridging the Gap from Biotech to Clinic.
We help biotechs navigate emerging clinical access pathways.
97 Went